The ICRS is the main forum for international collaboration in cartilaginous tissue research and joint preservation. Recognizing that there is a continuum from cartilage injury to degenerative joint disease we bring together basic scientists, clinical researchers, physicians, other healthcare providers and members of industry, engaged or interested in the field of articular biology, its genetic basis and regenerative medicine.


Return to Sport and Work Following Osteochondral Autograft Transplantation
Influences of antiplatelet therapy on the quality of Platelet-rich plasma (PRP) and efficacy of the PRP therapy
Engineering the Damaged Cartilage Interface to Direct Stem Cell Behavior
Chitosan oligomers alter the entire knee microenvironment when IA-injected post-bone marrow stimulation in a chronic defect rabbit model
Articular cartilage-derived progenitors from healthy and osteoarthritic human cartilage show potential for cartilage repair treatment
Diagnostic Scope Vs. Cartilage Procedure: Who Will Progress?
Allogeneic Umbilical Cord Blood-derived MSCs for Knee Osteoarthritis: Randomized Clinical Trial (with 5-year Follow-up Study)
Microfracture Augmentation with Enzymatic Pretreatment And Growth Factor Functionalized Self-Assembling Peptide Hydrogel Scaffold
Anti-coagulation influences properties of extracellular vesicles isolated from autologous blood derived products
Prospective study comparing PRP combined with Hyaluronic acid and Adipose derived MSC in patients with early OA knee
Five-year follow-up of the IMPACT trial:  One-stage cell based cartilage repair using recycled chondrons and allogeneic MSCs
Comparing efficacy of newer PRP (Chitosan PRP) over PRP (Platelet rich plasma) in an experimental guinea pig knee osteoarthritis model
Platelet lysate for cartilage regeneration: Improved redifferentiation after expansion, but opposite effects in 3D culture
Brief High Intensity Interval Exercise Increases Platelets and TGF in Platelet-rich Plasma
Duration effects of a single intra-articular injection of Autologous Protein Solution (APS) in patients with knee osteoarthritis (OA)
Platelet-Rich Plasma Powder - dose dependent effects on chondrocytes in a standardized model
Etiology of Cartilage Lesions Does Not Affect Clinical Outcomes of Patellofemoral Autologous Chondrocyte Implantation
Autologous chondrocyte implantation for bipolar chondral lesions in the patellofemoral compartment
Neuromuscular Control and Strength 1-year following Autologous Chondrocyte Implantation (ACI) and 5-Year Patient-Reported Outcomes
Amniotic Suspension Allograft (ASA) for Treatment of Knee Osteoarthritis in a Randomized Controlled Multi-Center Trial
Trochlear Dysplasia Does Not Affect the Outcomes of Patellofemoral Autologous Chondrocyte Implantation
Hypertension Increases Graft Failure Rate After Autologous Chondrocyte Implantation